Retatrutide is a new medication in the fight against obesity. This novel drug, classified as a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By boosting these receptors, Retatrutide https://roryccxb250830.blogsmine.com/36669823/tirzepatide-a-promising-new-treatment-for-obesity